US$ 27.98
intermittent fasting and glp-1 Comparative Framework: Therapy vs. vs Intermittent Fasting and GLP-1 |
Description
Claim CME for this episode HERE

Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness

Many early peptide programs relied on acute or high-dose administration, which produced adverse effects unrelated to therapeutic exposure levels

doi:10.1161/CIRCULATIONAHA.125.074545 Marx N, Husain M, Lehrke M, Verma S, Sattar N
